Plasma p‐tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study

ABSTRACT Background Plasma p‐tau181 has proven to be a promising diagnostic and prognostic tool in the earliest phases of Alzheimer's disease (AD). We aimed to evaluate the prognostic role of p‐tau181 in predicting conversion to AD dementia and worsening in cognition in mild cognitive impairment (MC...

Descripció completa

Dades bibliogràfiques

Autors principals:	Giulia Giacomucci, Assunta Ingannato, Chiara Crucitti, Silvia Bagnoli, Elisa Marcantelli, Sonia Padiglioni, Valentina Moschini, Carmen Morinelli, Laura Falsini, Sandro Sorbi, Valentina Berti, Benedetta Nacmias, Valentina Bessi
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-12-01
Col·lecció:	Annals of Clinical and Translational Neurology
Matèries:	Alzheimer's disease cognitive worsening mild cognitive impairment plasma biomarkers plasma p‐tau181 subjective cognitive decline
Accés en línia:	https://doi.org/10.1002/acn3.70190
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!